The estimated Net Worth of Richard D. Gorelick is at least $1.98 Million dollars as of 14 November 2017. Richard Gorelick owns over 1,500 units of Integra Lifesciences Corp stock worth over $379,544 and over the last 12 years Richard sold IART stock worth over $1,599,005.
Richard has made over 7 trades of the Integra Lifesciences Corp stock since 2013, according to the Form 4 filled with the SEC. Most recently Richard sold 1,500 units of IART stock worth $70,785 on 14 November 2017.
The largest trade Richard's ever made was selling 7,000 units of Integra Lifesciences Corp stock on 27 August 2014 worth over $350,210. On average, Richard trades about 911 units every 55 days since 2013. As of 14 November 2017 Richard still owns at least 21,565 units of Integra Lifesciences Corp stock.
You can see the complete history of Richard Gorelick stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is 311 C ENTERPRISE DRIVE, , PLAINSBORO, NJ, 08536.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig, and George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: